Alpha Profiles · Company Profile

IDEAYA Biosciences, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/ideaya-biosciences-inc

Entity: Public listing published
Primary listing: NASDAQ: IDYA
Verification: Partially verified
Last reviewed: 2026-09-17T04:45:46.769627+00:00

Overview

Alpha's canonical identity and public leadership record for IDEAYA Biosciences, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

9 public records

Andres Ruiz Briseno

Chief Accounting Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191501Apr 29, 2026

Daniel W. Snyder

Chief Legal Officer

State: confirmed
Effective: From Apr 29, 2026
Confidence: 94%
Evidence: IDYA DEF 14A executive officersApr 29, 2026

Darrin M. Beaupre

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191501Apr 29, 2026

Douglas B. Snyder

Chief Legal Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191501Apr 29, 2026

Jason S. Throne

Chief Legal Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: IDYA executive roster sourceMay 3, 2026

Joshua Bleharski

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191501Apr 29, 2026

Michael A. White

Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191501Apr 29, 2026

Stuart C. Dorman

Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191501Apr 29, 2026

Yujiro S. Hata

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191501Apr 29, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 17, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.